Max Planck Institute Develop Breakthrough
Synthesis Method for key anti-malarial drug
Artemisinin, using Vapourtec flow system.
January 17th 2012
|
Scientists at the laboratory of Peter Seeberger in the Max Planck Institute in Potsdam, Germany, have developed a new synthesis route that makes it possible for the best anti-malarial drug, Artemisinin , to be manufactered in sufficient quantity, and at a low enough price, for world demand to be affordably met.
Using a Vapourtec R Series system and a photo reactor they developed at the institute, researchers were able to synthesise Artemisinin from more easily obtainable Artemisinic acid. |
Prof Peter Seeberger (left) and Francois Levesque (co-authors on the publication) in front of the equipment used - including the Vapourtec R Series flow chemistry system. |
|
More information - Vapourtec
|
 |
 |
Find out more about the Vapourtec R Series flow chemistry platform used for this work. | |
 |
 Download Vapourtec R Series Brochure |
|
 |
FREE bimonthly email newsletter highlighting latest developments and publications in flow chemistry (such as this) when they happen. |
|
|
|
|
More information - The research work |
 |
|
|
|
The equipment close up
On the left, the Vapourtec R Series
On the right, the lightproof cabinet containing the photochemical reactor
